What is the minimal effective dose of Brintellix (vortioxetine)?

Minimal Effective Dose of Brintellix (Vortioxetine)

The minimal effective dose of Brintellix (vortioxetine) for major depressive disorder is 5 mg once daily, though 10 mg daily demonstrates more robust and consistent efficacy with earlier separation from placebo.

Evidence-Based Dosing Recommendations

Starting Dose

• Begin with 5 mg once daily 1, 2
• This represents the lowest FDA-approved dose that demonstrates statistically significant antidepressant effects compared to placebo
• Meta-analysis confirms 5 mg/day shows treatment response superior to placebo (OR=1.84,95% CI=1.16-2.93, p=0.010) 2

Clinical Efficacy by Dose

The dose-response relationship for vortioxetine is well-established:

• 5 mg/day: Effective but with smaller effect size (Δ-2.27 from placebo, p<0.01) 1

  • Achieves response but not consistently remission
  • May be appropriate for patients sensitive to side effects

• 10 mg/day: More robust efficacy (Δ-3.57 from placebo, p<0.01) 1

  • Separates from placebo by week 4
  • Represents a practical balance of efficacy and tolerability
  • Significantly improves 9 of 10 MADRS single-item scores 1

• 20 mg/day: Maximum efficacy (Δ-4.57 from placebo, p<0.01) 1, 3

  • Separates from placebo as early as week 2
  • Significantly superior to 10 mg/day (difference -1.03 MADRS points, p<0.05) 3
  • In flexible-dose studies, 64.3% of patients ultimately required 20 mg/day 3

Dose Escalation Strategy

For patients requiring dose adjustment after SSRI/SNRI failure 4:

• Rapid escalation to 20 mg/day by day 8 (second week) is both effective and well-tolerated
• This aggressive approach achieves remission in 32-55% of treatment-resistant patients
• Does not increase nausea incidence despite rapid titration

For initial treatment 5:

• The estimated 50% effective dose (ED50) is 4.37 mg/day
• The near-maximal effective dose (ED95) is 17.93 mg/day
• Visual dose-response curves suggest efficacy plateau may not be reached even at 20 mg/day

Tolerability Considerations

Nausea is the primary dose-limiting side effect:

• Significantly more common with vortioxetine 5 mg vs placebo (OR=3.01,95% CI=2.22-4.09) 2
• However, tolerability profile remains similar between 10 mg and 20 mg doses 3
• Other common adverse effects (dizziness, headache, dry mouth, diarrhea) show no significant dose-dependent increase 2

Clinical Algorithm

1. Start at 5 mg once daily for most patients
2. Increase to 10 mg after 1 week if well-tolerated
3. Consider 20 mg by week 2 in:
   • Patients with prior SSRI/SNRI failure
   • Severe depression requiring rapid response
   • Patients tolerating lower doses without adequate response
4. Assess response at 4-8 weeks at target dose before declaring treatment failure

Important Caveats

• While 5 mg is the minimal effective dose, 10 mg represents the minimal dose for consistent, clinically meaningful improvement in most patients
• The dose-response relationship continues beyond current FDA-approved maximum (20 mg), suggesting potential benefit at higher doses, though this requires further study 5
• Nearly half of patients in real-world flexible-dosing studies required dose escalation to 20 mg within the first week 3